drug

methohexital

1 story · latest Oct 9, 2026

Follow methohexital. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jun 1960 · NDA011559
Brand: Brevital Sodium

Relationships

Developed by Par Health, Inc

Also known as

methohexital sodium

Timeline

Par Health recalls two lots of Brevital Sodium over particulate matter

Oct 9Safetymethohexital Par Health, Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.